Chicago
,
US
29 - 31 March 2025
American College of Cardiology (ACC 2025)
Presentation schedule and materials
Saturday, 29 March 2025
09:50
CST
102-09
Publication
The Effect of Once-Weekly Subcutaneous Semaglutide on Functional Capacity in People with Type 2 Diabetes and Peripheral Artery Disease: Primary Results From the Phase 3b, Randomized, Placebo-Controlled, Double Blind STRIDE Trial
Marc P. Bonaca1; Andrei-Mircea Catarig2; Kim Houlind3,4*; Bernhard Ludvik5; Joakim Nordanstig6; Chethana Kalmady Ramesh7; Neda Rasouli8; Harald Sourij9; Alex Videmark2; Subodh Verma10
MATERIALS AVAILABLE
12:30
CST
11283
Publication
Clinical Burden of Acute Myocardial Infarction in U.S. Hospitals: A Real-world Study
Lei Lv1; Jeffrey R. Skaar1; Carey Robar1; Sunday Ikpe2; Shanthi Krishnaswami2; Zhun Cao2; Michael G. Nanna3
MATERIALS AVAILABLE
13:30
CST
104-07
Publication
Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial
Darren K. McGuire1; Neil R. Poulter2; Rodica Pop-Busui3; Sharon L. Mulvagh4; Nikolaus Marx5; Johannes Mann6,7; Silvio E. Inzucchi8; Scott Emerson9; John E. Deanfield10; Matthew A Cavender11; Stephen C. Bain12; Maria Sejersten Ripa13; G. Kees Hovingh13; Mette Gislum13; Kirstine Brown-Frandsen13; Mads Engelmann13; Jens-Peter David13; John B. Buse11
MATERIALS AVAILABLE
Sunday, 30 March 2025
09:36
CST
947-09
Publication
Effect of the GLP-1 receptor agonist semaglutide on total cardiovascular events in patients with cardiovascular disease and overweight or obesity but no diabetes in the SELECT trial
A. Michael Lincoff1; Helen M. Colhoun2; Scott S. Emerson3; G. Kees Hovingh4; M. Giray Kabakci5; Steven E. Kahn6; Ildiko Lingvay7; Ana Laura S.A. Matos4; Cristobal Morales-Portillo8; Søren Rasmussen4; Jose F.K. Saraiva9; Benjamin M. Scirica10; Francisco J. Tinahones11; Philippe Van de Borne12; Subodh Verma13; Peter E. Weeke4; Donna H. Ryan14; John Deanfield15
MATERIALS AVAILABLE
10:00
CST
9741
Publication
Lower Risk of MACE and All-Cause Death in Patients Initiated on Semaglutide 2.4 mg in Routine Clinical Care: Results from the SCORE Study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World)
Zhenxiang Zhao1; Jinlin Song2; Mads Faurby1; Wojciech Michalak1; Yan Chen2; Joanna Boland2; B. Gabriel Smolarz1; Mikhail Kosiborod3*
MATERIALS AVAILABLE
12:30
CST
Symposium
Systemic inflammation in CVD: Perspectives in heart failure
Sanjiv Shah
;
Brittany Weber
;
Marat Fudim
MATERIALS AVAILABLE
Monday, 31 March 2025
09:12
CST
11280
Publication
Cardiovascular outcomes in new users of once-weekly GLP-1 receptor agonists vs other glucose-lowering therapies among Medicare beneficiaries with type 2 diabetes and established atherosclerotic cardiovascular disease
Adam de Havenon1; Xi Tan2; Sina Noshad3; Joanna Harton3; Yuanjie Liang2; Lin Xie2; Josh Noone2
MATERIALS AVAILABLE
Keywords